Navigation Links
MDS Responds to AECL and Government of Canada Announcements Regarding Maple Project
Date:5/16/2008

TORONTO, May 16 /PRNewswire-FirstCall/ - Earlier this morning, Atomic Energy of Canada Ltd. (AECL) announced it would discontinue the development of the MAPLE reactors at Chalk River, but remains committed to providing ongoing supply of medical isotopes.

MDS Inc., a leading provider of products and services to the global life sciences markets, was not consulted by AECL about this decision, and the company is evaluating these developments. MDS Nordion, a business unit of MDS, is a leading provider of medical isotopes and radiopharmaceuticals.

"The most important issue has always been the continuity of medical isotope supply for patients worldwide," said Stephen P. DeFalco, President and CEO, MDS Inc. "We are pleased that the government has asked AECL to pursue the extension of the NRU operation beyond its current license and to ensure the ongoing supply of these critical medical isotopes."

MDS is disappointed that AECL has stated it will not complete the MAPLE project despite significant investment and effort over the past 12 years. The company will evaluate all options and pursue appropriate steps to protect the interests of patients, its customers and its shareholders.

About MDS

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and the diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Undeterred Despite the Obstacles: American Refugee Committee Responds to Tragedy in Myanmar
2. Aid Urgently Needed in Myanmar (Burma): Lutheran World Relief Responds
3. Neuralstem Responds to Incorrect StemCells, Inc. Release on Patents
4. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
5. The Toy Industry Association Responds to Washington State Law Governing the Sale of Toys and the Governors Veto of Key Sections of the Bill
6. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
7. DRAXIS Responds to Trading
8. Maternal love: How a mothers brain responds to her infant
9. DuPont Responds to Spelter, W.Va. Lawsuit Rulings
10. Blue Cross of California Responds to Recent Media Coverage of Rescission
11. Veterans for Americas (VFA) Wounded Warrior Outreach Program Responds to Fort Drum in Aftermath of Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: